AXA SA (CS.PA)
FR0000120628 - Common Stock
We assign a fundamental rating of 6 out of 10 to CS. CS was compared to 30 industry peers in the Insurance industry. Both the profitability and the financial health of CS get a neutral evaluation. Nothing too spectacular is happening here. CS has a correct valuation and a medium growth rate. Finally CS also has an excellent dividend rating. With these ratings, CS could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
CS had positive earnings in the past year.
CS had a positive operating cash flow in the past year.
CS had positive earnings in each of the past 5 years.
CS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CS has a better Return On Assets (1.12%) than 64.29% of its industry peers.
With a decent Return On Equity value of 15.16%, CS is doing good in the industry, outperforming 67.86% of the companies in the same industry.
CS has a Return On Invested Capital of 1.32%. This is in the better half of the industry: CS outperforms 60.71% of its industry peers.
CS had an Average Return On Invested Capital over the past 3 years of 1.23%. This is in line with the industry average of 2.12%.
The last Return On Invested Capital (1.32%) for CS is above the 3 year average (1.23%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROIC | 1.32% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
1.3 Margins
CS has a Profit Margin of 8.20%. This is comparable to the rest of the industry: CS outperforms 46.43% of its industry peers.
In the last couple of years the Profit Margin of CS has grown nicely.
With a decent Operating Margin value of 11.69%, CS is doing good in the industry, outperforming 60.71% of the companies in the same industry.
In the last couple of years the Operating Margin of CS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A |
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
CS has less shares outstanding than it did 1 year ago.
CS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CS has about the same debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.34, we must say that CS is in the distress zone and has some risk of bankruptcy.
CS has a Altman-Z score of 0.34. This is amongst the best in the industry. CS outperforms 89.29% of its industry peers.
CS has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as CS would need 3.32 years to pay back of all of its debts.
CS has a better Debt to FCF ratio (3.32) than 67.86% of its industry peers.
CS has a Debt/Equity ratio of 0.57. This is a neutral value indicating CS is somewhat dependend on debt financing.
CS's Debt to Equity ratio of 0.57 is fine compared to the rest of the industry. CS outperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 0.34 |
ROIC/WACC0.13
WACC10.4%
2.3 Liquidity
CS has a Current Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.00, CS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CS has a Quick Ratio of 1.00. This is a normal value and indicates that CS is financially healthy and should not expect problems in meeting its short term obligations.
CS's Quick ratio of 1.00 is amongst the best of the industry. CS outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.49% over the past year.
Measured over the past years, CS shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.03% on average per year.
The Revenue for CS has decreased by -11.35% in the past year. This is quite bad
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
3.2 Future
Based on estimates for the next years, CS will show a small growth in Earnings Per Share. The EPS will grow by 6.06% on average per year.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y8.13%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
EPS Next 5Y6.06%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y6.02%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.37 indicates a reasonable valuation of CS.
64.29% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CS to the average of the S&P500 Index (26.91), we can say CS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.20, the valuation of CS can be described as reasonable.
Based on the Price/Forward Earnings ratio, CS is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CS to the average of the S&P500 Index (23.26), we can say CS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.37 | ||
| Fwd PE | 8.2 |
4.2 Price Multiples
64.29% of the companies in the same industry are more expensive than CS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.18 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CS may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)0.32
EPS Next 2Y9.64%
EPS Next 3Y7.88%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.75%, CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.08, CS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.75% |
5.2 History
The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
CS pays out 62.10% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.1%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
AXA SA
EPA:CS (1/13/2025, 5:29:59 PM)
33.505
-0.34 (-0.99%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners41.04%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap74.19B
Analysts80.71
Price Target40.39 (20.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.75% |
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.43%
Revenue NY rev (3m)-4.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.37 | ||
| Fwd PE | 8.2 | ||
| P/S | 0.85 | ||
| P/FCF | 9.18 | ||
| P/OCF | 8.67 | ||
| P/B | 1.57 | ||
| P/tB | 3.03 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.23
EY9.64%
EPS(NY)4.08
Fwd EY12.19%
FCF(TTM)3.65
FCFY10.89%
OCF(TTM)3.87
OCFY11.54%
SpS39.51
BVpS21.38
TBVpS11.07
PEG (NY)1.28
PEG (5Y)0.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROCE | 1.63% | ||
| ROIC | 1.32% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A | ||
| FCFM | 9.24% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.55% | ||
| Interest Coverage | 1.51 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 112.61% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 0.34 |
F-Score7
WACC10.4%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y8.13%
EPS Next 2Y9.64%
EPS Next 3Y7.88%
EPS Next 5Y6.06%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y6.02%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year26.06%
EBIT Next 3Y9.55%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%